logo
A pause in NIH funding leaves these Alzheimer's studies in limbo: ‘This is alarming'

A pause in NIH funding leaves these Alzheimer's studies in limbo: ‘This is alarming'

CNN24-04-2025

Zahydie Burgos Ribot and her husband, Francisco Rios, are checking items off their travel bucket list and spending quality time together before Francisco will no longer be able to travel – and before his brain forgets.
The Florida-based couple recently crossed Alaska off the list. Their next trip will be to Niagara Falls.
'We have a whole schedule,' Ribot said. 'We're choosing to live every single day with a lot of intention.'
That's because they know that Rios' window to easily create new memories is closing. About three years ago, at age 46, he was diagnosed with early-onset Alzheimer's disease.
Although Rios has been doing well on a new treatment he receives through a clinical trial, Ribot is increasingly afraid that the study could be hindered by cuts to federal funding of biomedical research.
The Trump administration has been conducting a restructuring of the US Department of Health and Human Services as well as a review of funding, resulting in the abrupt cancellation of hundreds of research grants under the National Institutes of Health and many others left in limbo, waiting for a decision on whether their funding will be renewed.
In March, 14 of 35 Alzheimer's Disease Research Centers had their funding halted by the NIH as the administration stopped $65 million in funding for research, according to Democratic lawmakers.
CNN has contacted HHS and the White House for comment.
'This is alarming, because these are critical data that inform not only prognosis but inform trajectory of the disease and inform future treatments,' Ribot said.
Rios also has been following these developments and remains worried about his future.
'He just asked me, 'Am I going to continue getting the trial?' But he was crying and literally ripping the skin off his fingers because of the anxiety,' Ribot said. 'He knows what's at stake. He is aware. He wants to continue the medication.'
Rios has been participating in a clinical trial conducted by Washington University in St. Louis in which he has been receiving the Alzheimer's drug Leqembi paired with an experimental therapy called E2814, given as intravenous infusions, to help slow his Alzheimer's symptoms.
Ribot credits the trial with helping curb Rios' memory loss and cognitive decline.
Before Rios was diagnosed, he began to emotionally withdraw and disconnect from loved ones. He even got lost while driving to a routine doctor's appointment about 10 minutes from their home, Ribot said.
She initially thought he was showing signs of depression. But Rios' doctor realized that something else was happening in his brain and referred him to the Young-Onset Dementias Clinic at Johns Hopkins in Baltimore.
'They ran more tests, and they ran the genetic testing, and that's when we had the final confirmation that it was Alzheimer's,' Ribot said.
If funding for Rios' clinical trial is curtailed, she said, not only could he and the other participants lose access to the medications that they hope are giving them more time to live normally, the development of other impactful Alzheimer's treatments could be delayed.
About a dozen Alzheimer's disease research centers are still waiting for their federal funding to be renewed, said Dr. Michael Greicius, professor of neurology and neurological sciences at the Stanford University School of Medicine, whose Alzheimer's center is among those awaiting a decision.
'Our five-year renewal was reviewed in October. Normally, we would have gotten a decision probably around February,' he said, adding that research funding for his team at the Stanford Alzheimer's Disease Research Center ran out about three weeks ago.
'It seems like we're moving towards renewal, but it's very hard to read the tea leaves, and that makes it really challenging when you're thinking about projects you'd like to undertake or hiring new research coordinators, for example,' he said.
Greicius and his colleagues had to hold off on starting research projects because they didn't know whether there will be funding coming in, he said.
The uncertainty around funding baffles him.
'It's hard to imagine a less political topic than Alzheimer's disease. I mean, it affects people from red states and blue states and purple states. It's so common. Almost everyone either has a relative in their family or at least has a friend who has a relative that's been affected by Alzheimer's disease,' Greicius said.
'It still seems like the easiest-to-agree-upon target for federally funded research, and yet it's not at all clear that this progress is going to continue,' he said. 'That, for me, is a large part of the frustration – just the uncertainty of it all.'
Preventive neurologist Dr. Richard Isaacson, founder of one of the first Alzheimer's prevention clinics in the United States, is also waiting to see whether his federal grants will be renewed.
'We're somewhere between limbo and purgatory,' he said.
Isaacson, who directs research at the Institute for Neurodegenerative Diseases in Florida, has developed free online software called RetainYourBrain, which aims to democratize access to brain health care. Users input their risk factors for Alzheimer's and receive a personalized risk assessment, as well as personalized recommendations and time-sensitive reminders on how to improve their brain health.
But without continued funding, 'it may never be released to the public,' Isaacson said.
Supporters of the funding cuts argue that the nation should reduce 'wasteful spending' and prioritize efficiency.
'With the government wanting to cut back on spending money, I get it. But Alzheimer's is one of the most expensive diseases to our health care system,' Isaacson said.
It's estimated that nearly 1 in every 6 Medicare dollars was spent on someone with the disease last year, according to the Alzheimer's Association, and the average per-person Medicare spending for older adults with Alzheimer's is estimated to be 2.8 times higher than average per-person spending for all other seniors.
'I feel that cutting Alzheimer's research that may save money over time, and doing it rapidly, is a bad investment,' Isaacson said.
While some studies are waiting to see if they'll continue, some studies have already had to take steps to shut down.
When the NIH canceled grants in March related to diversity, equity and inclusion, or DEI, some Alzheimer's studies were swept up in the consequences.
Federal funding for a multiyear study at the University of California, Davis' Alzheimer's Disease Research Center was abruptly terminated. This led the center's co-director, Dr. Charles DeCarli, to issue an appeal and fight to have the grant fully reinstated.
'The appeal had to be done within 30 days, and in the meantime, we had to shut down the study. So while I was working on the appeal, my team was doing all the things that closing a study needs to involve, which is hundreds of hours of work, notifying the 33 sites in this study,' he said.
DeCarli's appeal was successful. He won that battle but is still recovering from the turmoil.
'It was a very challenging month in my life,' DeCarli said. 'It just seems to me that the only reason that this was terminated is because it includes the word 'diverse' in the title.'
The study, titled 'The Clinical Significance of Incidental White Matter Lesions on MRI Amongst a Diverse Population with Cognitive Complaints (INDEED),' involves examining the effect that white matter injury in the brain and vascular issues may have on cognitive performance as well as health outcomes. The research was being funded by the NIH's National Institute of Neurological Disorders and Stroke.
Up to 25% of people who develop dementia later in life may have some type of vascular contributing factor to their disease, and DeCarli said his study could help 'lay out the foundation' for diagnostic tests and treatments for them.
'When these studies are terminated, an opportunity is lost to advance science,' he said.
Other studies may face similar threats to funding. According to a policy notice issued Monday, the NIH said it will begin pulling medical research funding from universities with diversity and inclusion programs and any boycotts of Israeli companies.
The agency 'reserves the right to terminate financial assistance awards and recover all funds' if grant recipients do not comply with federal guidelines barring diversity and equity research and 'prohibited boycotts,' the notice said.
The policy applies to 'domestic recipients of new, renewal, supplement, or continuation awards that are issued on or after' April 21, according to the notice.
Separately, the Washington-based nonprofit UsAgainstAlzheimer's has been tracking previously terminated grants and the funding cuts at the NIH that took place in March and earlier this month, and it warns that some cuts could stall the progress being made to find a cure for Alzheimer's disease.
'In the last 10 years, there have been groundbreaking advances in Alzheimer's disease research, in understanding where the disease comes from, and understanding how to diagnose the disease, and ultimately in how to treat the disease. But we don't have a cure yet,' said Russ Paulsen, chief operating officer at UsAgainstAlzheimer's.
'In looking through the list of grants that have been affected, it appears to cut across prevention, diagnosis, treatment and ultimately seeking a cure, as well as understanding the basics of the disease to start with,' he said. 'We've made huge progress, and now is not the time to take our foot off the accelerator.'
In the meantime, Ribot and Rios are trying to keep their heads up. They are keeping an eye on any new developments in research funding cuts while continuing to focus on their travel bucket list.
'While he's here and we're here, we're living our life. We are finding joy. Even when we cry, we laugh. Even when we are in despair, we have hope,' Ribot said.
'I'm not going to romanticize this disease, because that's not it – but there's still purpose and meaning and joy,' she said. 'We're not going to let this disease rob us of our present.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Senators grill NIH director on massive budget cuts
Senators grill NIH director on massive budget cuts

Yahoo

timean hour ago

  • Yahoo

Senators grill NIH director on massive budget cuts

National Institutes of Health Director Dr. Jay Bhattacharya faced critical questions from both Republican and Democratic senators Tuesday as he sought to defend the Trump administration's sweeping plans to reorganize the agency and slash budgets for medical research. Senate Appropriations Chairwoman Susan Collins (R-ME) swiftly criticized the current budget cuts and proposed changes, including a nearly 40% reduction to the National Institute of Aging's spending and 40% overall cuts to the agency's institutes. 'As the senator representing … the oldest state in the nation, this is a particular concern,' Collins said. 'I know personally what it means to so many American families.' The senator also said caps on indirect spending for universities are 'so poorly conceived' and have harmed U.S. medical research. 'It is leading to scientists leaving the United States for opportunities in other countries. It's causing clinical trials to be halted and promising medical research to be abandoned.' A federal court has paused the 15% cap on payments for indirect costs, but the administration assumed savings from the change in its 2026 fiscal year budget. Bhattacharya defended certain administrative changes while distancing himself from others, such as a pause on Northwestern University's grant funding, saying certain terminations happened before he assumed his role. In answering Sen. Tammy Baldwin (D-WI) about overall cuts, Bhattacharya took responsibility for other sweeping grant cancellations. 'There's changes in priorities at the NIH to move away from politicized science, I made those decisions,' he said. The hearing room was filled with purple-garbed advocates for Alzheimer's disease research and representatives of the American Cancer Society Cancer Action Network dressed in light blue. Baldwin harshly criticized the proposed $18 billion reduction to the NIH's total spending, saying cuts will resonate as the NIH funds 15,000 fewer medical research projects. 'While I think Congress will reject your budget request, it clearly shows the administration's intent,' Baldwin said. 'How is this proposal anything but intentionally sabotaging biomedical research?' Bhattacharya said he is 'happy to work with Congress' on the budget and more flexible spending on medical research.

Senate Democrats file bill to prevent ban on transgender military service
Senate Democrats file bill to prevent ban on transgender military service

Yahoo

time2 hours ago

  • Yahoo

Senate Democrats file bill to prevent ban on transgender military service

Democratic lawmakers will submit a bill in the Senate on Tuesday that would reverse the Pentagon's new ban on transgender military service members diagnosed with gender dysphoria who now face being forced out if they had not previously self-identified as transgender. The "Fit to Serve Act" would prohibit the Defense Department from banning transgender service members from serving in the military. If passed, the law would prevent the Defense Department from denying access to healthcare on the basis of gender identity, and it would also prohibit the military from forcing service members to serve in their sex assigned at birth. It would also make it illegal for the military to discriminate against service members on the basis of gender identity. MORE: Transgender US service members will be separated from military, Pentagon memo says The Defense Department's policy was required by an executive order signed by President Donald Trump on his first day in office that banned transgender individuals from serving in the military. In outlining the policy in a memo issued in late February, Defense Secretary Pete Hegseth wrote that " individuals who have a current diagnosis or history of, or exhibit symptoms consistent with, gender dysphoria are incompatible with the high mental and physical standards necessary for military service." "We recruit and train the best and bravest to protect our country -- losing highly qualified service members, who meet strict standards to join the military, makes us less safe," said Sen. Elizabeth Warren, D-Mass., who is the lead sponsor of the bill that is being filed in the Senate on Tuesday, which was first announced last month. "By prohibiting this discrimination on the basis of gender identity, this legislation will help to ensure transgender individuals who are qualified to serve may do so" said Sen. Marie Hirono, D-Hawaii, one of the bill's co-sponsors. Under the Pentagon's new policy, transgender service members had until June 6 to self-identify and begin the process of voluntary separation. With the passing of that deadline, the Pentagon has begun a process of involuntary separation of service members diagnosed with gender dysphoria, which is defined as "psychological distress that results from an incongruence between one's sex assigned at birth and one's gender identity." Ahead of that deadline, the Pentagon said more than 1,000 service members had self-identified as having been diagnosed with gender dysphoria. It is unclear whether that number increased ahead of the deadline or how officials had reached that estimate. National Guard and Reserve service members have until July 7 to self-identify for voluntary separation. MORE: Transgender service members say they face 'heartbreaking' decision amid Trump ban: Leave military or get kicked out The Pentagon's new ban went into effect in early May shortly after the Supreme Court ruled that the Trump administration could enforce the ban on transgender people in the military while legal challenges to the ban proceed in lower courts. Navy Cmdr. Emily Shilling, who is a lead plaintiff in one of the legal challenges, told ABC News that she has chosen to voluntarily separate. "Yes I am 'volunteering' to retire but I do want to make it clear that myself and most others I have spoken to in SPARTA feel it is under duress," said Shilling who is the president of Sparta Pride, an organization advocating for 2,400 transgender people in the military. "For me, it's the only way I believe I can continue to uphold my oath," said Shilling. "I'm stepping away from active duty service, but not service to my country. My fight is only beginning." Defense officials have said that as of last December, about 4,240 current active-duty, Guard and Reserve service members had been diagnosed with gender dysphoria. There are more than 2.1 million military service members serving on active-duty, Guard and the Reserves. Advocacy groups have put the actual number of transgender service members as being much higher, at around 15,000. Since 2014, the total number of diagnoses for gender dysphoria among service members was 5,773, with 1,000 of those having gone through gender-affirming surgery, according to a defense official. The total costs for treatments, hormones and surgeries during that time frame was $52 million, said the official. With the end of the voluntary separation period, transgender service members now face what could be a lengthy process that could end with their separation from military service. The process will begin with military commanders being told to identify people in their units who have a diagnosis or history of gender dysphoria or exhibit symptoms consistent with gender dysphoria. Once they have done that, a referral to an annual health checkup will be initiated, beginning what could be a lengthy process that could lead to their removal from the military. Pentagon officials have said those evaluations will be conducted during regularly scheduled annual physicals meaning it could be months before they take place. The Pentagon incentivized service members with gender dysphoria to voluntarily separate ahead of the June 6 deadline by offering benefit payment packages that would be more than double what would be received if they were to separate involuntarily. Those who voluntarily separated would not have to risk paying back the recruitment or retention bonuses they may have earned during their military service. The Democratic senators argue that instead of improving military readiness the implementation of the ban will have the opposite effect. "This ban undermines our military readiness and national security by removing thousands of talented, experienced service members and signaling to potential recruits that the military does not respect them, their colleagues, their family, or their friends simply because of who they are," said a description of the Fit to Serve Act. "It also wastes billions of taxpayer dollars invested in training these troops to become leaders to keep all of us safe." The bill is co-sponsored in the Senate by Warren, Hirono, Tammy Duckworth (Illinois), Kirsten Gillibrand (New York), Tammy Baldwin (Wisconsin), Ed Markey (Massachusetts), Ron Wyden (Oregon), Jeff Merkley (Oregon),John Fetterman (Pennsylvania), Chris Van Hollen (Maryland), Bernie Sanders (Vermont), Andy Kim (New Jersey), and Cory Booker (New Jersey). Congressmen Adam Smith (Washington) Mark Takano (California), Chrissy Houlahan (Pennsylvania), Sara Jacobs (California), and Eric Sorensen (Illinois) are sponsoring the legislation in the House of Representatives. "By prohibiting this discrimination on the basis of gender identity, this legislation will help to ensure transgender individuals who are qualified to serve may do so," Hirono said. It remains to be seen how much bipartisan support the legislation could gain and whether it will be able to clear Republican majorities in both the Senate and the House. "If you are willing to risk your life for our country and you can do the job, it shouldn't matter if you are gay, straight, transgender, Black, white or anything else," said Duckworth who added that the ban "is disruptive to our military, hurts readiness and not only does nothing to strengthen our national security -- it actively makes things worse." "The Fit to Serve Act is a declaration that we will not stand by while our courageous troops are under political assault. Transgender service members meet the same rigorous standards, deploy worldwide, put in the same hard work and demonstrate the same dedication as any of their colleagues" said Jennifer Pike Bailey, Government Affairs Director of the Human Rights Campaign, one of the advocacy groups supporting the legislation. "President Trump and Secretary Hegseth are taking away their jobs, cutting off their health care benefits, and disregarding the immense sacrifices these service members and their families have made. It's a slap in the face to all who serve and puts our military readiness at risk," she added. "At a time when the United States faces growing threats around the world, banning them from the All-Volunteer Force will make Americans less safe," said Luke Schleusener, CEO of Out in National Security. "This legislation underscores that the fight to honor the service of thousands of transgender Americans in uniform -- and to strengthen America's national security -- is far from over." ABC's Deena Zaru contributed to this report.

"We dissent": NIH scientists sign declaration against Trump's research cuts
"We dissent": NIH scientists sign declaration against Trump's research cuts

Yahoo

time2 hours ago

  • Yahoo

"We dissent": NIH scientists sign declaration against Trump's research cuts

National Institute of Health scientists signed a declaration decrying the cuts to healthcare and medical research by the Trump administration on Monday. Ninety-two scientists added their names to a letter, the Bethesda Declaration, which calls out the Trump administration's handling of the NIH and the cutting of more than 2,100 research grants and contracts, totaling more than $12 billion in federal funding. The letter, named for NIH's headquarters in Maryland, expresses the scientists' "dissent" and outrage over Trump administration policies "that undermine the NIH mission, waste public resources, and harm the health of Americans and people across the globe." The declaration points to canceled studies, including work on the long-lasting effects of COVID-19 and climate change-related health impacts. "Ending a $5 million research study when it is 80% complete does not save $1 million," the declaration states, "it wastes $4 million." Along with the 92 named signatories, more than 250 scientists at the NIH signed the declaration anonymously. "We include anonymous signers and speak for countless others at NIH," the letter concluded, "who share our concerns but who — due to a culture of fear and suppression created by this Administration — chose not to sign their names for fear of retaliation."The declaration was delivered to NIH Director Jay Bhattacharya on Monday. Bhattacharya said the declaration "has some fundamental misconceptions about the policy directions the NIH has taken in recent months." "Nevertheless," he continued, "respectful dissent in science is productive. We all want the NIH to succeed."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store